Microneedling — Dermapen Collagen Induction

Dermapen microneedling at MarBelle Clinic uses a motorised Dermapen device to create thousands of micro-perforations across the treatment surface, triggering the skin's natural wound-healing response — specifically the fibroblast-driven collagen and elastin production that follows any controlled skin injury. The treatment is effective for brightening skin tone, softening fine lines, reducing acne scarring, improving texture uniformity, and boosting hydration. A numbing cream is applied before every session. The exosome add-on enhances healing and amplifies collagen output; both are physician-administered for precision depth control.

Microneedling — also called collagen induction therapy (CIT) — works by creating an array of microscopic injury channels in the skin, each barely wider than a hair. These micro-injuries trigger a cascade of events that mirrors the body's natural tissue repair: within minutes, platelets accumulate and begin releasing growth factors; within hours, fibroblasts migrate toward the injury zones; over the following weeks and months, type I and type III collagen is deposited and the extracellular matrix reorganises. The Dermapen device at MarBelle Clinic uses a motorised needle cartridge that oscillates vertically at high speed, producing controlled penetration depths that the physician adjusts depending on the zone and concern being treated: shallower settings (0.25–0.5mm) for superficial brightening and skinbooster-effect enhancement; deeper settings (1.0–2.0mm) for established acne scars and significant texture issues; and intermediate depths for overall skin quality work. This adjustability is a key advantage over manual dermarollers, which have a fixed angle that reduces precision. The controlled micro-channels also serve as temporary pathways for topical active ingredient delivery — immediately after needling, the skin's permeability increases dramatically. At MarBelle, the exosome add-on exploits this window: extracellular vesicles derived from mesenchymal stem cells are applied to the needled skin immediately post-treatment. These vesicles carry concentrated growth factor payload (EGF, TGF-β, FGF, PDGF) and mRNA molecules that communicate directly with dermal fibroblasts, stimulating collagen production beyond what the needling alone achieves and simultaneously reducing the inflammatory phase — typically resulting in a faster, more comfortable recovery. Standard session protocol: numbing cream is applied 30–45 minutes before treatment; the skin is cleansed and the physician performs the systematic needling pass across the face; the session takes approximately 15–20 minutes of active treatment. The skin appears pink-red immediately after, similar to moderate sunburn. The exosome variant follows the needling with serum application and a brief absorption period. Healing time is one to two days: redness resolves; mild dryness or fine peeling may occur on days two to three. For meaningful skin transformation, a series of five to seven sessions at two-to-four-week intervals is recommended. Results accumulate across the series as successive collagen-building responses layer over each other. Patients typically notice ongoing improvement for two to three months after completing the course as the last stimulated collagen fibres mature.